The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.

The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by binding to the same receptor. This prevents the agonist drug from activating the receptor and producing its intended effect. For example, naloxone, a competitive antagonist, can block the effects of opioid drugs by binding to opioid receptors and reversing their activation.

In addition, functional or physiological antagonism occurs when a drug binds to a different receptor and produces a physiological response that opposes the effect of the agonist-bound receptor. For example, histamine stimulates acid secretion, while omeprazole prevents acid secretion by inhibiting the proton pump. These drugs can be considered functional antagonists.

Some drugs follow chemical antagonism, which involves the combination of two drugs to form an inactive product. Examples include chelating agents like dimercaprol, which bind to heavy metals and reduce their toxicity. The neutralizing antibody infliximab, which sequesters the inflammatory cytokine tumor necrosis factor (TNF), has an anti-inflammatory effect.

Antagonism can also occur through pharmacokinetic interactions, where one drug affects another drug's absorption, distribution, metabolism, or elimination. For instance, if a drug increases the metabolism or elimination of another drug, it can decrease the concentration and effectiveness of the second drug, leading to antagonistic effects.

Tags
AntagonismDrug InteractionReceptor BindingAllosteric ModulationFunctional InteractionChemical ReactionsPharmacokinetic ProcessesReceptor AntagonismCompetitive AntagonistOpioid ReceptorsPhysiological AntagonismChelating AgentsInfliximabTumor Necrosis Factor TNFDrug Metabolism

Del capítulo 4:

article

Now Playing

4.14 : Combined Effects of Drugs: Antagonism

Pharmacodynamics

6.9K Vistas

article

4.1 : Principios de Acción de las Drogas

Pharmacodynamics

5.2K Vistas

article

4.2 : Objetivos para la acción de los medicamentos: Visión general

Pharmacodynamics

4.5K Vistas

article

4.3 : Transducción de señales: descripción general

Pharmacodynamics

7.8K Vistas

article

4.4 : Mecanismo del transductor: Receptores acoplados a proteínas G

Pharmacodynamics

1.4K Vistas

article

4.5 : Receptor de canal iónico activado por ligando: mecanismo de compuerta

Pharmacodynamics

1.7K Vistas

article

4.6 : Mecanismo del transductor: receptores ligados a enzimas

Pharmacodynamics

2.0K Vistas

article

4.7 : Mecanismo del Transductor: Receptores Nucleares

Pharmacodynamics

984 Vistas

article

4.8 : Relación dosis-respuesta: Introducción

Pharmacodynamics

2.1K Vistas

article

4.9 : Relación Dosis-Respuesta: Potencia y Eficacia

Pharmacodynamics

3.1K Vistas

article

4.10 : Relación Dosis-Respuesta: Selectividad y Especificidad

Pharmacodynamics

5.8K Vistas

article

4.11 : Índice terapéutico

Pharmacodynamics

3.4K Vistas

article

4.12 : Interacción Fármaco-Receptor: Agonista

Pharmacodynamics

1.9K Vistas

article

4.13 : Interacción Fármaco-Receptor: Antagonista

Pharmacodynamics

1.9K Vistas

article

4.15 : Efectos combinados de los medicamentos: sinergismo

Pharmacodynamics

2.6K Vistas

See More

JoVE Logo

Privacidad

Condiciones de uso

Políticas

Investigación

Educación

ACERCA DE JoVE

Copyright © 2025 MyJoVE Corporation. Todos los derechos reservados